Ironwood reports Q3 EPS 24c, consensus 12c

Reports Q3 revenue $122.06M, consensus $75.7M. “LINZESS delivered a strong third-quarter performance, driven by accelerated double-digit prescription demand growth combined with improved net pricing, which prompted us to raise our full-year 2025 financial guidance. Importantly, we expect our strong third-quarter revenue will result in substantial fourth-quarter cash flows, which will strengthen our financial position, enable us to reduce our debt and maintain compliance with debt covenants over the coming quarters,” said Tom McCourt, chief executive officer of Ironwood (IRWD).